Skip to content

Active Drainage vs. Passive Drainage in MRM

Comparison Between Active Drainage And Passive Drainage In Post-Operative Seroma Formation After Modified Radical Mastectomy In Female Patients With Breast Carcinoma: A Prospective Randomized Controlled Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07621575
Acronym
MRM Drains
Enrollment
157
Registered
2026-06-02
Start date
2024-05-30
Completion date
2025-11-15
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brest Cancer, Drain Effect, Modified Radical Mastectomy, Seroma Formation

Keywords

active Vs passive /MRM/suction drain

Brief summary

The aim of the study is to compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in female patient with breast carcinoma as regard of: Primary Outcomes: 1. Daily drain output (measured in mL/day). 2. Duration of the drain in place. 3. Amount of seroma aspiration after the drain removal. 4. Number of days till the last seroma aspiration. Secondary Outcomes: 1. Flap necrosis. 2. Surgical site infection. 100 female divided into two equal groups: * Group A: Active drainage group (50 patients). * Group B: Passive drainage group (50 patients). After MRM ,drain output was measured daily using a graduated jar by nurse during hospital stay which was a one to two days in an average and then by patient himself. All the data was recorded on a paper sheet. In passive drain, breast and axilla outcomes were combined together as one read to be equal to one active drain gar. Twice per week, I checked this reading by myself and reported any complications).

Interventions

PROCEDUREcompare active and passive drain

compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in in amount ,duration, respiration ,respiration duration ,SSI and skin necrosis

Sponsors

MOHAMED GAMAL AHMED ARAKEEB
Lead SponsorOTHER
Kafrelsheikh University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Female patient diagnosed with breast carcinoma planned for MRM

Exclusion criteria

* • Previous breast surgery. * Active infection. * Recurrent or metastatic breast cancer (Stage IV). * Un-controlled diabetes mellitus (HbA1C \>7). * Coagulopathy disease. * Use of anticoagulant or antiplatelet medications. * Bilateral breast cancer. * Loss to follow-up within one month of drain removal. * Pregnancy. * Male breast cancer patients.

Design outcomes

Primary

MeasureTime frameDescription
Daily drain output (mL/day)7 weeks for each caseamount of drain output (mL/day)

Secondary

MeasureTime frameDescription
Duration of the drain in place (in days)7 weeks for each casenumber of days of the drain in place
Amount of seroma aspiration after the drain removal (mL)7 weeks for each caseseroma aspirated in mL
Number of days till the last seroma aspiration (in days)7 weeks for each caseNumber of days till the last seroma aspiration
Flap necrosis7 weeks for each case
Surgical site infection.7 weeks for each case

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026